Related Experiment Video
Updated: Jun 29, 2026

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Neurophysiologic abnormalities in children with Charcot-Marie-Tooth disease type 1A
Eppie M Yiu1, Joshua Burns, Monique M Ryan
1Children's Neuroscience Centre, Royal Children's Hospital, Melbourne, Victoria, Australia.
Insights
Neurophysiologic abnormalities are present in all children with Charcot-Marie-Tooth disease type 1A (CMT1A) from age two. Motor nerve conduction slowing progresses until age six, then stabilizes, with reduced muscle action potential amplitudes noted early.
Area of Science:
- Neurology
- Pediatrics
- Genetics
Background:
- Charcot-Marie-Tooth disease type 1A (CMT1A) is a common inherited neuropathy.
- Limited large-scale studies detail pediatric neurophysiologic features of CMT1A.
Purpose of the Study:
- To characterize the neurophysiologic findings in a large cohort of children with CMT1A.
- To describe the age-related progression of neurophysiologic abnormalities in pediatric CMT1A.
Main Methods:
- Median motor and sensory nerve conduction studies were performed on 80 children aged 2-16 years with CMT1A.
- Analysis focused on nerve conduction velocity, distal motor latency, and compound muscle action potential (CMAP) amplitude.
Main Results:
- All children exhibited neurophysiologic abnormalities.
- Median motor nerve conduction velocity was <33 m/s, slowing significantly in older children (7-16 years).
- Prolonged distal motor latencies and reduced CMAP amplitudes were observed from an early age, with attenuated age-related increases.
Conclusions:
- Neurophysiologic abnormalities are universal in pediatric CMT1A, detectable from age two.
- Motor conduction slowing progresses through the first six years of life.
- Reduced CMAP amplitudes and attenuated age-related increases are key findings in childhood CMT1A.
Abstract:
Although Charcot-Marie-Tooth disease type 1A (CMT1A) initially manifests in the first decade, there are no large studies describing its neurophysiologic features in childhood. We report neurophysiologic findings in 80 children aged 2-16 years with CMT1A who underwent median motor and sensory nerve conduction studies. Neurophysiologic abnormalities were present in all children. Median motor nerve conduction velocity was invariably less than 33 m/s (mean 18.7 m/s, range 9.0-32.9 m/s), with conduction velocities significantly slower in children aged 7-16 years compared with children aged 6 years and below. All children had prolonged distal motor latencies (mean 7.3 ms, range 4.0-12.3 ms). The compound muscle action potential (CMAP) amplitude was reduced from an early age (mean 7.1 mV, range 2.1-13.5 mV), and its normal increase with age was attenuated. Median sensory responses were present in only seven children, all aged less than 9 years and with slowed sensory conduction. Neurophysiologic abnormalities are present in all children with CMT1A from the age of 2 years. Motor conduction slowing progresses through the first 6 years of life and thereafter remains stable. CMAP amplitude is reduced from an early age, and the normal physiologic increase with age is attenuated. Median sensory responses may be recorded in younger children, and their presence does not exclude the diagnosis of CMT1A.
Related Concept Videos
Alterations in Muscle Tone lll
Alterations in Muscle Tone ll
Myasthenia Gravis ll: Pathophysiology
Huntington Disease l: Introduction
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Parkinson Disease ll: Pathophysiology

